Literature DB >> 29191297

Verification of Heart Disease: Implications for a New Heart Transplantation Allocation System.

Pejman Raeisi-Giglou1, E Rene Rodriguez2, Eugene H Blackstone3, Carmela D Tan2, Eileen M Hsich4.   

Abstract

OBJECTIVES: This study sought to determine the accuracy of the pre-transplantation clinical diagnosis of heart disease in the United Network for Organ Sharing (UNOS) database.
BACKGROUND: Because survival on the heart transplantation waitlist depends on underlying heart disease, a new allocation system will include the type of heart disease. Accuracy of the pre-transplantation clinical diagnosis and the effect of misclassification are unknown.
METHODS: We included all adults who received transplants at our center between January 2009 to December 2015. We compared the pre-transplantation clinical diagnosis at listing with pathology of the explanted heart and determined the potential effect of misclassification with the proposed allocation system.
RESULTS: A total of 334 patients had the following clinical cardiac diagnoses at listing: 148 had dilated cardiomyopathy, 19 had restrictive cardiomyopathy, 103 had ischemic cardiomyopathy, 24 had hypertrophic cardiomyopathy, 11 had valvular disease, 16 had congenital heart disease (CHD), and 13 patients had a diagnosis of "other." Pathology of the explanted hearts revealed 82% concordance and 18% discordance (10% coding errors and 8% incorrect diagnosis). The most common incorrect diagnoses were sarcoidosis (66%), arrhythmogenic right ventricular dysplasia (60%), and other causes of predominately right-sided heart failure (33%). Among the misclassified diagnoses, 40% were listed as UNOS status 2, 8% remained at status 2 at transplantation, and only sarcoidosis and CHD were potentially at a disadvantage with the new allocation.
CONCLUSIONS: There is high concordance between clinical and pathologic diagnosis, except for sarcoidosis and genetic diseases. Few misclassifications result in disadvantages to patients based on the new allocation system, but rare diseases like sarcoidosis remain problematic. To improve the UNOS database and enhance outcome research, pathology of the explanted hearts should be required post-transplantation.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  dilated cardiomyopathy; heart failure; restrictive cardiomyopathy sarcoidosis; transplantation

Mesh:

Year:  2017        PMID: 29191297      PMCID: PMC5726587          DOI: 10.1016/j.jchf.2017.09.022

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  6 in total

1.  Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies.

Authors:  A Uemura; S Morimoto; S Hiramitsu; Y Kato; T Ito; H Hishida
Journal:  Am Heart J       Date:  1999-08       Impact factor: 4.749

2.  Does Survival on the Heart Transplant Waiting List Depend on the Underlying Heart Disease?

Authors:  Eileen M Hsich; Joseph G Rogers; Dennis M McNamara; David O Taylor; Randall C Starling; Eugene H Blackstone; Jesse D Schold
Journal:  JACC Heart Fail       Date:  2016-05-11       Impact factor: 12.035

3.  [Clinicopathologic analysis of dilated heart in cardiac transplant recipients].

Authors:  Feng-Ying Lü; Lai-Feng Song; Lei Liu; Hong Zhao; Hong-Yue Wang; Li Li; Lin-Lin Wang; Qing-Zhi Wang; Wen-Xue Si; Lian-Zhuang Zhang; Xiao-Hui Li; Ran-Xu Zhao
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2007-12

4.  Do clinical diagnoses correlate with pathological diagnoses in cardiac transplant patients? The importance of endomyocardial biopsy.

Authors:  Adriana Luk; Mohammed Metawee; Eric Ahn; F Gustafsson; Heather Ross; Jagdish Butany
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

5.  Transplant data: sources, collection, and caveats.

Authors:  David M Dickinson; Paula C Bryant; M Christian Williams; Gregory N Levine; Shiqian Li; James C Welch; Berkeley M Keck; Randall L Webb
Journal:  Am J Transplant       Date:  2004       Impact factor: 8.086

6.  Morphologic features of the recipient heart in patients having cardiac transplantation and analysis of the congruence or incongruence between the clinical and morphologic diagnoses.

Authors:  William C Roberts; Carey Camille Roberts; Jong Mi Ko; Giovanni Filardo; John Edward Capehart; Shelley Anne Hall
Journal:  Medicine (Baltimore)       Date:  2014-07       Impact factor: 1.889

  6 in total
  2 in total

1.  Recurrent cardiac sarcoidosis after heart transplantation.

Authors:  Giacomo Veronese; Manlio Cipriani; Duccio Petrella; Stefano Geniere Nigra; Patrizia Pedrotti; Andrea Garascia; Gabriella Masciocco; Manuela A Bramerio; Karin Klingel; Maria Frigerio; Enrico Ammirati
Journal:  Clin Res Cardiol       Date:  2019-05-09       Impact factor: 5.460

Review 2.  Arrhythmias in Cardiac Sarcoidosis Bench to Bedside: A Case-Based Review.

Authors:  Lynda E Rosenfeld; Mina K Chung; Clifford V Harding; Paolo Spagnolo; Johan Grunewald; Jason Appelbaum; William H Sauer; Daniel A Culver; Jose A Joglar; Ben A Lin; Christine L Jellis; Timm-Michael Dickfeld; Deborah H Kwon; Edward J Miller; Paul C Cremer; Frank Bogun; Jordana Kron; Ashley Bock; Davendra Mehta; Paul Leis; Konstantinos C Siontis; Elizabeth S Kaufman; Thomas Crawford; Peter Zimetbaum; Edwin T Zishiri; Jagmeet P Singh; Kenneth A Ellenbogen; Jonathan Chrispin; Syed Quadri; Logan L Vincent; Kristen K Patton; Steven Kalbfleish; Thomas D Callahan; Francis Murgatroyd; Marc A Judson; David Birnie; David R Okada; Christopher Maulion; Pavan Bhat; Lavanya Bellumkonda; Ron Blankstein; Richard K Cheng; Maryjane A Farr; Jerry D Estep
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-02-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.